MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027

1 hour ago 2

Article content

Net cash used in operating activities was $4.0 million, compared with $4.2 million in the prior-year period, despite the increase in operating expenses, reflecting the non-cash nature of much of the G&A increase. Cash was $7.6 million at July 31, 2026, compared with $11.3 million at April 30, 2026, before the US$30 million facility commitment described below.

Article content

Subsequent Event

Article content

On September 14, 2026, MindWalk announced a binding commitment from Sanabil (Cayman) for a senior unsecured revolving credit facility of up to US$30 million at a fixed 7.00% interest rate, drawn as needed. The facility carries no financial maintenance covenants, no warrants or conversion feature, and no pledge of MindWalk assets. Proceeds are intended to support MindWalk’s shift to recurring, platform-based revenue: onboarding ReefIQ™ and LensAI™ enterprise clients as agreements are signed, and participating in the platform partnerships that increasingly define its commercial model, along with its biologics programs, working capital, and general corporate purposes. The term sheet is binding on both parties, and MindWalk and Sanabil (Cayman) will negotiate a definitive credit agreement with a target closing within 60 days.

Article content

Conference Call and Webcast Details

Article content

Event Date and Time:

Article content

Monday, September 14, 2026, at 5:00 p.m. Eastern Time

Article content

The conference call will be webcast live and available for replay via a link provided in the Events section of the Company’s Investor Relations pages at: https://ir.mindwalkai.com/events-and-presentations/default.aspxAnalyst registration URL:https://events.q4inc.com/analyst/231176031?pwd=m63SIFiSWebcast Attendee URL: https://events.q4inc.com/attendee/231176031 Anyone listening to the call is encouraged to read the Company’s periodic reports available on the Company’s profile at www.sedarplus.ca and www.sec.gov, including the discussion of risk factors and historical results of operations and financial condition in those reports.

Article content

About MindWalk Holdings Corp.

Article content

MindWalk Holdings Corp. (NASDAQ: HYFT) is a Bio-Native AI company building the BioIntelligence infrastructure that life sciences AI and agentic AI require, integrating AI, data, and advanced wet lab capabilities into one connected discovery ecosystem. At its core is HYFT® Technology, a proprietary, function-aware representation of biology. Its HYFT pattern-objects span sequence and structural biology and, refined over 20 years of curation, form a continuously evolving biological representation of 660 million patterns and 25 billion relationships. This enriched biological representation is the architecture behind ReefIQ™, the biological data substrate that provides context for life sciences, enriching data at ingestion and growing more valuable with each program run on it, and LensAI™, the reasoning and application layer for target discovery, candidate diligence, portfolio decision support, and the agentic AI workflows pharmaceutical companies are now deploying. By design, value compounds in this HYFT representation layer, not in any individual AI model that runs on top of it.

Article content

Article content

Investor Contact

Article content

Louie Toma, CPA, CFA, Managing Director, CoreIR, [email protected]Trademarks HYFT® is a registered trademark of MindWalk Holdings Corp. ReefIQ™ and LensAI™ are trademarks of MindWalk Holdings Corp. or its subsidiaries; ReefIQ™ registration is pending. All other trademarks are the property of their respective owners.

Article content

Forward-Looking Statements

Article content

This press release contains forward-looking statements within the meaning of applicable United States and Canadian securities laws. Forward-looking statements are based on management’s current expectations and assumptions and are subject to known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially, including: risks relating to MindWalk’s history of net losses and its ability to achieve or sustain profitability; the level and trend of operating cash usage and MindWalk’s ability to fund operations; the risk that MindWalk and the lender do not negotiate and execute a definitive credit agreement, or do not do so by the target closing date, and MindWalk’s ability to satisfy the conditions to closing and to drawing under the facility; the market acceptance and commercial outcomes of ReefIQ™ and LensAI™, including the ability to convert engagements into contracted, recurring arrangements; the build-out and certification of compliance capabilities for regulated workloads; the technical performance of AI-based discovery methods and of the underlying compute infrastructure; the outcomes and financial effects of the divestiture of non-core operations; intellectual property risks, including the status and scope of pending patent applications; the ability to enter into pharmaceutical, infrastructure, or other partnership arrangements; competition; regulatory determinations; and capital markets conditions. Additional information is available in MindWalk’s Annual Report on Form 20-F and other filings on SEDAR+ (sedarplus.ca) and EDGAR (sec.gov/edgar). Except as required by law, MindWalk undertakes no obligation to update any forward-looking statement. [Legal to review tailored risk factors before issuance.]

Article content

The reconciliation of Net Loss to Adjusted EBITDA from continuing operations is presented in the table below:

Article content

Three months ended
July 31,

(in thousands)

2026
$

2025
$

Net loss

(6,085)

(4,088)

Income taxes

158

(91)

Amortization and depreciation

266

201

Foreign exchange realized loss

(23)

136

Interest expense

55

59

Interest, accretion and other income

(18)

(5)

Unrealized foreign exchange loss

(184)

31

Share-based payments

740

55

Adjusted EBITDA

(5,091)

(3,702)

Article content

Article content

*All financial figures are in Canadian Dollars (CAD) unless otherwise stated.

Article content

MINDWALK HOLDINGS CORP.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited – Expressed in Canadian dollars)

Three months ended July 31,

(in thousands, except share data)

2026
$

2025
$

REVENUE

3,834

3,161

COST OF SALES

1,588

1,634

GROSS PROFIT

2,246

1,527

EXPENSES

Research and development

1,285

1,049

Sales and marketing

3,196

1,343

General and administrative

3,894

3,294

8,375

5,686

Loss before other income (expenses) and income taxes

(6,129)

(4,159)

OTHER INCOME (EXPENSES)

Grant income

6

Interest, accretion and other income

18

5

Unrealized foreign exchange loss

184

(31)

202

(20)

Loss before income taxes and discontinued operations

(5,927)

(4,179)

Income taxes

(158)

91

NET LOSS FROM CONTINUING OPERATIONS

(6,085)

(4,088)

NET INCOME FROM DISCONTINUED OPERATIONS

1,129

NET LOSS FOR THE PERIOD

(6,085)

(2,959)

OTHER COMPREHENSIVE INCOME (LOSS)

Items that will be reclassified subsequently to loss

Exchange difference on translating foreign operations

(18)

70

COMPREHENSIVE LOSS FOR THE PERIOD

(6,103)

(2,889)

LOSS PER SHARE FROM CONTINUING OPERATIONS– BASIC AND DILUTED

(0.13)

(0.09)

INCOME PER SHARE FROM DISCONTINUED OPERATIONS– BASIC AND DILUTED

0.02

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING

46,807,089

46,154,118

Article content

MINDWALK HOLDINGS CORP.

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(Unaudited – Expressed in Canadian dollars)

(in thousands)

July 31,
2026
$

April 30,
2026
$

ASSETS

Current assets

Cash

7,623

11,348

Amounts receivable, net

2,020

2,529

Taxes receivable

347

472

Inventory

611

492

Unbilled revenue

851

581

Prepaid expenses

762

798

12,214

16,220

Restricted cash

128

126

Deposit on equipment

26

25

Property and equipment

3,997

4,047

Deferred tax asset

958

958

Total assets

17,323

21,376

LIABILITIES

Current liabilities

Accounts payable and accrued liabilities

5,442

4,178

Deferred revenue

529

1,073

Income taxes payable

188

81

Leases

483

457

6,642

5,789

Leases

3,001

3,069

Deferred income tax liability

769

769

Total liabilities

10,412

9,627

SHAREHOLDERS’ EQUITY

Share capital

137,788

137,263

Contributed surplus

14,848

14,108

Accumulated other comprehensive income

3,103

3,121

Accumulated deficit

(148,828)

(142,743)

6,911

11,749

Total liabilities and shareholders’ equity

17,323

21,376

Article content

MINDWALK HOLDINGS CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the three months ended July 31, 2026 and 2025

(Unaudited – Expressed in Canadian dollars)

Three months ended July 31,

(in thousands)

2026
$

2025
$

Operating activities:

Net loss for the period

(6,085)

(2,959)

Items not affecting cash:

Amortization and depreciation

266

942

Foreign exchange

(142)

41

Share-based expense

740

55

(5,221)

(1,921)

Changes in non-cash working capital related to operations:

Amounts receivable

581

(850)

Inventory

(119)

(84)

Unbilled revenue

(237)

(627)

Prepaid expenses

39

(329)

Accounts payable and accrued liabilities

1,216

(986)

Sales and income taxes payable and receivable

214

279

Deferred revenue

(515)

305

Net cash used in operating activities

(4,042)

(4,213)

Investing activities:

Purchase of property and equipment

(78)

(282)

Deferred acquisition payments

(312)

Net cash used in investing activities

(78)

(594)

Financing activities:

Proceeds on share issuance, net of transaction costs

525

(48)

Repayment of leases

(179)

(323)

Net cash used in financing activities

346

(371)

Increase (decrease) in cash during the period

(3,774)

(5,178)

Cash included in asset held for sale

(646)

Foreign exchange

51

57

Cash – beginning of the period

11,474

10,791

Cash – end of the period

7,751

5,024

Cash is comprised of:

Cash

7,623

4,897

Restricted cash

128

127

7,751

5,024

Cash paid for interest

Cash paid for income tax

Cash from discontinued operations:

Net cash used in operating activities

754

Net cash used in investing activities

(100)

Net cash used in financing activities

(359)

Article content

*All financial figures are in Canadian Dollars (CAD) unless otherwise stated.

Article content

Source: MindWalk Holdings Corp.

Article content

Article content

Article content

Article content

View source version on businesswire.com:

Article content

Article content

logo

Article content

Contacts

Article content

Investor Relations Contact
Louie Toma, CPA, CFA
Managing Director, CoreIR
[email protected]

Article content

Read Entire Article